The current status of the platelet 5-HT(2A) receptor in depression

Journal of Affective Disorders

Volumn 57, Issue 1-3, 2000, Pages 13-24

  Mendelson, Scott D ^a  

^a UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

Author keywords

5 HT(2A) receptors; Calcium mobilization; Depression; Platelet aggregation; Platelets; Serotonin

Indexed keywords

ACUTE PHASE PROTEIN; CALCIUM; PHOSPHATIDYLINOSITIDE; SEROTONIN; SEROTONIN 2A RECEPTOR;

BIPOLAR DEPRESSION; CALCIUM MOBILIZATION; DEPRESSION; DISEASE SEVERITY; HUMAN; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; REVIEW; RISK; STRESS; SUICIDAL BEHAVIOR; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

BLOOD PLATELETS; DEPRESSIVE DISORDER; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; PROTEIN BINDING; RECEPTORS, SEROTONIN;

EID: 0034598432     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(99)00177-9     Document Type: Review

References (105)

1. Adelstein R.S., Conti M.A. The characterization of contractile proteins from platelets and fibroblasts. Cold Spring Harbor Symp. Quant. Biol. 37:1972;599-605.
2. 2-receptor stimulation in human blood platelets. Naunyn Schmiedeberg's Arch. Pharmcol. 325:1984;337-342.
3. Apfelbaum M.E. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells. Neuroendocrinology. 67:1998;45-50.
4. 3H-LSD) in the blood-platelets of depressed patients. Life Sci. 44:1989;725-734.
5. Arora R.C., Meltzer H.Y. Serotonin-2 receptor binding in blood platelets of schizophrenic patients. Psychiatry Res. 47:1993;111-119.
6. Bagdy G. Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav. Brain Res. 73:1996;277-280.
7. Bakish D., Cavazzoni P., Chudzik J., Ravindran A., Hrdina P. Effects of selective reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol. Psychiatry. 41:1997;184-190.
8. Berk M., Bodemer W., Van Oudenhove T., Butkow N. The platelet intracellular calcium response to serotonin is augmented in bipolar manic and depressed patients. Hum. Psychopharmacol. 10:1995;189-193.
9. Berk M., Kessa K., Szabo C.P., Butkow N. The augmented platelet intracellular calcium response to serotonin in anorexia nervosa but not bulemia may be due to subsyndromal depression. Int. J. Eating Disord. 22:1997;57-63.
10. Berk M., Mitchell V.S., Plein H. The platelet intracellular response to serotonin in subsyndromal depression. Int. Clin. Psychpharmacol. 13:(3):1998;107-110.
11. Biegon A., Weizman A., Karp L., Ram A., Tiano S., Wolff M. Serotonin 5-HT2 receptor binding on blood platelets - A peripheral marker for depression? Life Sci. 41:1987;2485-2492.
12. Biegon A., Essar N., Israeli M., Elizur A., Bruch S., Bar-Nathan A.A. Serotonin 5-HT2 receptor binding on blood platelets as a state dependent marker in major affective disorder. Psychopharmacology (Berl.). 102:1990;73-75.
13. 2 receptor binding of blood platelets of suicidal men. Psychopharmacology (Berl.). 100:1990;165-167.
14. Born G.V.R., Juengjaroen K., Michal F. Relative activities on and uptake by human platelets of 5-hydroxytryptamine and several analogues. Br. J. Pharmacol. 44:1972;117-139.
15. Bothwell R.A., Eccleston D., Marshall E. Platelet intracellular calcium in patients with recurrent affective disorders. Psychopharmacology. 114:1994;375-381.
16. Bowden C.L., Huang L.G., Javors M.A., Johnson J.M., Seleshi E., McIntyre K., Contreras S., Maas J.W. Calcium function in affective disorders and healthy controls. Biol. Psychiatry. 23:(4):1988;367-376.
17. 125I]-LSD binding and 5-HT induced shape change in human platelets. Br. J. Pharmacol. 93:1988;189P.
18. Brusov O.S., Beliaev B.S., Kataonov A.B., Zlobina G.P., Factor M.I., Lideman R.R. Does platelet serotonin receptor supersensitivty accompany endogenous depression? Biol. Psychiatry. 25:1989;375-381.
19. Butler J., Leonard B.E. The platelet serotonergic system in depression and following sertraline treatment. Int. Clin. Psychopharmacol. 3:1988;343-347.
20. Cook E.H. Jr., Fletcher K.E., Wainwright M., Marks N., Yan S.Y., Leventhal B.L. Primary structure of the human platelet serotonin 5HT2A receptor: Identity with frontal cortex serotonin 5HT2A receptor. J. Neurochem. 63:1994;465-469.
21. Cowen P.J. Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation. Clin. Neuropharmacol. 16:(Suppl. 3):1993;S6-18.
22. Cowen P.J., Geaney D.P., Schachter M., Green A.R., Elliot J.M. Desipramine treatment in normal subjects: Effects on neuroendocrine responses to tryptophan and on platelet serotonin (5-HT-related receptors. Arch. Gen. Psychiatry. 43:1986;61-67.
23. Cowen P.J., Charig E.M., Fraser S., Elliot J.M. Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment. J. Affect. Disord. 13:1987;45-50.
24. 2 receptor sites. J. Biol. Chem. 260:1985;7603-7608.
25. Delisi S.M., Konopka L.M., O'Conner F.L., Crayton J.W. Platelet cytosolic calcium responses to serotonin in depressed patients and controls - relationship to symptomology and medication. Biol. Psychiatry. 43:(5):1998;327-334.
26. Delisi S.M., Konopka L.M., Russell K., O'Conner F.L., Cooper R., Crayton J.W. Platelet cytosolic calcium hyperresponsivity to serotonin in patients with hypertension and depressive symptoms. Biol. Psychiatry. 45:1999;1035-1041.
27. Du, L., Bakish, D., Lapierre Y.D., Ravindran A.V., Hrdina, P.D., 1999. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Neuropsychiatr. Genet. (in press).
28. Dubovsky S.L., Christiano J., Daniel L.C., Franks R.D., Murphy J., Adler L., Baker N., Harris A. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Arch. Gen. Psychiatry. 46:1989;632-638.
29. Dubovsky S.L., Thomas M. Serotonergic mechanisms and current and future psychiatric practice. J. Clin. Psychiatry. 56:(Suppl 2):1995;38-48.
30. Dunn E.J., Coote M., Browne G., Steiner M. Biological 'markers' in dysthymia. Biol. Psychiatry. 39:1996;526.
31. 2 receptor stimulation in platelets of depressed patients. Biol. Psychiatry. 34:1993;565-568.
32. Ellis P.M., Salmond C. Is platelet imipramine binding reduced in depression? A meta-analysis. Biol. Psychiatry. 36:1994;292-299.
33. 2-Adrenoceptor-mediated inhibition of platelet adenylate cyclase and induction of aggregation in major depression. Effect of long-term cyclic antidepressant drug treatment. Arch. Gen. Psychiatry. 47:1990;125-132.
34. Healy D., Calvin J., Whitehouse A.M., White W., Wilton-Cox H., Theodorou A.E., Lawrence K.M., Horton R.W., Paykel E.S. Alpha-1-acid glycoprotein in major depression and eating disorders. J. Affect. Disord. 22:1991;13-20.
35. Healy D., Carney P.A., Leonard B.E. Monoamine-related markers of depression: Changes following treatment. J. Psychiatr. Res. 17:1983;251-260.
36. Healy D., Carney P.A., O'Halloran A., Leonard B.E. Peripheral adrenoceptors and serotonin receptors in depression. Changes in association with response to treatment with trazodone or amitriptyline. J. Affect. Disord. 9:1985;285-296.
37. Holmsen H. Platelet metabolism and activation. Semin. Hematol. 22:1985;219-240.
38. 2 receptors. J. Psychiatry Neurosci. 20:1995;11-19.
39. Hrdina P.D., Bakish D., Ravindran A., Chudzik J., Cavazzoni P., Lapierre Y.D. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry Res. 66:1997;73-85.
40. Hutton R.A., Mikhailidis D.P., Georgiadis E., Hyden A., Ginsburg J. The effect of tetracosactrin and corticosteroids on platelet aggregation: An in vivo and in vitro study. Thromb. Res. 17:1980;5-11.
41. Jorgensen K.A., Freund L., Sorensen P. The effect of prednisone on platelet function tests. Scand. J. Hematol. 28:(2):1982;118-121.
42. 2 receptor-mediated function in depressed patients: Investigation by measuring 5-HT-induced shape change of blood platelets. Jpn. J. Psychiatr. Neurol. 46:1992;169-174.
43. Karege F., Bovier P., Hilleret H., Gaillard J.-M., Tissot R. Adrenaline-induced platelet aggregation in depressed patients and control subjects. Neuropsychobiology. 27:1993;21-25.
44. Kawabata A., Hata T. Characterization of platelet hypofunction in rats under SART stress (repeated cold stress). Thromb. Res. 69:1993;197-207.
45. Kehoe W.A., Kwentus J.A., Sheffel W.B., Harralson A.F. Increased alpha-1-acid glycoprotein in depression lowers free fraction of imipramine. Biol. Psychiatry. 29:1991;489-493.
46. Konopka L.M., Cooper R., Crayton J.W. Serotonin-induced increases in platelet cytosolic calcium concentration in depressed, schizophrenic, and substance abuse patients. Biol. Psychiatry. 39:1996;708-713.
47. 2+ response in human platelets. Life Sci. 48:1991;2405-2412.
48. 2+ response is increased in the blood platelets of depressed patients. Biol. Psychiatry. 30:1991;310-312.
49. Kusumi I., Koyama T., Yamashita I. Thrombin-induced platelet calcium mobilization is enhanced in bipolar disorders. Biol. Psychiatry. 32:1992;731-734.
50. Kusumi I., Koyama T., Yamashita I. Serotonin-induced platelet intracellular calcium mobilization in depressed patients. Psychopharmacology. 113:1994;322-327.
51. Le Breton G.C., Dinerstein R.J., Roth L.J., Feinberg H. Direct evidence for intracellular divalent cation distribution associated with platelet shape change. Biochem. Biophys. Res. Commun. 71:1976;362-370.
52. Lowther S., De Paermentier F., Crompton M.R., Katona C.L.E., Horton R.W. Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment. Brain Res. 642:1994;281-289.
53. Maes M., Scharpe S., Meltzer H.Y., Bosmans E., Suy E., Calabrese J., Cosyns P. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res. 49:1993;11-27.
54. Maes M., Smith R., Scharpe S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology. 30:1995;111-116.
55. Maes M., Van der Planken M., Van Gastel A., Desnyder R. Blood coagulation and platelet aggregation in major depression. J. Affect. Disord. 40:1996;35-40.
56. Malyszko J., Urano T., Takada Y., Takada A. Time-dependent changes in platelet aggregation, fibrinolytic activity, and peripheral serotonergic measures in rats subjected to water immersion restraint stress. Haemostasis. 24:1994;236-242.
57. 2 and β-adrenergic receptor binding in the frontal cortex of suicide victims. Arch. Gen. Psychiatry. 43:1986;954-959.
58. Mann J.J., McBride A., Brown R.P., Linnoila M., Leon A.C., DeMeo M., Mieczkowski T., Myers J.E., Stanley M. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch. Gen. Psychiatry. 49:1992;442-446.
59. McAdams C., Leonard B.E. Changes in platelet aggregatory responses to collagen and 5-hydroxytryptamine in depressed, schizophrenic and manic patients. Int. Clin. Psychopharmacol. 7:1992;81-85.
60. McAdams C., Colohan F.J., Brophy J., Leonard B.E. Alteration by a plasma factor of platelet aggregation and 5HT uptake in depression. Biol. Psychiatry. 32:1992;296-298.
61. 2 receptor indices to major depressive disorder, personality traits, and suicidal behavior. Biol. Psychiatry. 35:1994;295-308.
62. 2 receptor on human platelets. Life Sci. 40:1987;1799-1809.
63. McNamara P.J., Jewell R.C., Gillespie M.N. Interaction of alpha-1-acid-glycoprotein with endogenous autocoids, in particular, platelet activating factor (PAF). Prog. Clin. Biol. Res. 300:1989;307-319.
64. Meltzer H.Y. Mode of action of lithium in affective disorders. An influence on intracellular calcium functions. Pharmacol. Toxicol. 66:(Suppl. 3):1990;84-99.
65. Meltzer H.Y., Arora R.C. Platelet serotonin studies in affective disorders: Evidence for a serotonergic abnormality. Sandler M., Coppen A., Harnett S. 5-Hydroxytryptamine in Psychiatry. A Spectrum of Ideas. 1990;50-89 University Press, New York.
66. Mikuni M., Kusumi I., Kagaya A., Kuroda Y., Mori H., Takahashi K. Increased 5-HT-2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 15:1991;49-61.
67. Mikuni M., Kagaya A., Takahashi K., Meltzer H.Y. Serotonin but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorders. Psychopharmacology (Berl.). 106:1992;311-314.
68. Musselman M.L., Tomer A., Manatunga A.K., Knight B.T., Porter M.R., Kasey S., Marzec U., Harker L.A., Nemeroff C.B. Exaggerated platelet reactivity in major depression. Am. J. Psychiatry. 153:1996;1313-1317.
69. Nelson E.C., Cloninger R.C., Pryzybeck T.R., Csernansky J.G. Platelet serotonergic markers and tridimensional personality questionnaire measures in a clinical sample. Biol. Psychiatry. 40:1996;271-278.
70. 1-acid glycoprotein, a putative endogenous inhibitor of the tritiated imipramine binding site, in depressed patients. Arch. Gen. Psychiatry. 47:1990;337-340.
71. Neuger J., El Khoury A., Kjellman B.F., Wahlund B., Aberg-Wistedt A., Stain-Malmgren R. Platelet serotonin functions in untreated major depression. Psychiatry Res. 85:1999;189-198.
72. Nugent D.F., Dinan T.G., Leonard B.E. Alteration by a plasma factor(s) of platelet aggregation in unmedicated unipolar depressed patients. J. Affect. Disord. 31:1994;61-66.
73. Nugent D.F., Dinan T.G., Leonard B.E. Further characterization of the inhibition of platelet aggregation by a plasma factor(s) in unmedicated unipolar depressed patients. J. Affect. Disord. 33:1995;227-231.
74. Owens M.J., Ballenger C.A., Knight D.L., Nemeroff C.B. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat. J. Pharmacol. Ther. 278:(3):1996;1040-1049.
75. 2+ response, and 5-HT content in winter seasonal affective disorder. Biol. Psychiatry. 36:1994;458-466.
76. Pandey G.N., Pandey S.C., Janicak P.G., Marks R.C., Davis J.M. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol. Psychiatry. 28:1990;215-222.
77. Pandey G.N., Pandey S.C., Dwivedi Y., Sharma R.P., Janicak P.G., Davis J.M. Platelet serotonin-2A receptors: A potential biological marker for suicidal behavior. Am. J. Psychiatry. 152:1995;850-855.
78. Peroutka S.J., Snyder S.H. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science. 210:1980;88-90.
79. Pfeffer C.R., McBride P.A., Anderson G.M., Kakuma T., Fensterheim L., Khait V. Peripheral serotonin measures in prepubertal psychiatric inpatients and normal children: Associations with suicidal behavior and its risk factors. Biol. Psychiatry. 44:1998;568-577.
80. Piletz J.E., Chikkala D., Khaitan L., Jackson K., Qu Y. Delayed desensitization of a α2-adrenoceptor-mediated platelet aggregation in depressed patients. Neuropsychopharmacology. 9:1993;55-66.
81. 2A receptor and low blood serotonin in suicidal psychiatric patients. Pharmacopsychiatry. 38:1998;84-89.
82. Roevens P., de Chaffoy de Courcelles D. Desensitization and resensitization of human platelets to 5-hydroxytryptamine at the level of signal transduction. Biochem. J. 307:1995;775-782.
83. 3H]paroxetine binding sites in platelets from depressed patients. J. Affect. Disord. 52:1999;225-233.
84. Rosenthal N.E., Sack D.A., Gillin J.C., Lewy A.J., Goodwin F.K., Davenport Y., Muellers P.S., Newsome D.A., Wehr T.A. Seasonal affective disorder: A description of the syndrome and preliminary findings with light therapy. Arch. Gen. Psychiatry. 41:1984;72-80.
85. Sheline Y.I., Bardgett M.E., Jackson J.L., Newcomer J.W., Csernansky J.G. Platelet serotonin markers and depressive symptomology. Biol. Psychiatry. 37:1995;442-447.
86. Sheline Y.I., Black K.J., Bardgett M.E., Csernansky J.G. Platelet binding characteristics distinguish placebo responders from nonresponders in depression. Neuropsychopharmacology. 12:1995;315-322.
87. Simonsson P., Traskman-Bendz L., Alling C., Oreland L. Peripheral serotonergic markers in patients with suicidal behavior. Eur. Neuropsychopharmacol. 1:1991;503-510.
88. 3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapy. Biol. Psychiatry. 45:1999;464-470.
89. Sneddon J.M. Blood platelets as a model for monoamine containing neurones. Prog. Neurobiol. 1:1972;153-198.
90. 1-acid glycoprotein. Arch. Intern. Med. 136:1976;778-781.
91. 3H]LSD) binding in healthy volunteers. Psychopharmacology. 133:(1):1997;39-42.
92. Stahl S.M. The human blood platelet: A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch. Gen. Psychiatry. 34:1977;509-516.
93. Stain-Malmgren R., Kjellman B.F., Aberg-Wistedt A. Platelet serotonergic functions and light therapy in seasonal affective disorder. Psychiatry Res. 78:1998;163-172.
94. 2 receptor binding after electroconvulsive therapy in depression. J. Electroconvuls. Ther. 14:(1):1998;15-24.
95. 2 binding sites in the frontal cortex of suicide victims. Lancet. i:1983;214-216.
96. Sumner B.E.H., Fink G. Estrogen increases the density of 5-hydroxytryptamine(2A) receptors in cerebral cortex and nucleus accumbens in the female rat. J. Steroid Biochem. Mol. Biol. 54:1995;15-20.
97. Tamir H., Payette R.F., Huang Y.L., Liu K.P., Gershon M.D. Human seronectin: a blood glycoprotein that binds serotonin and is associated with platelets and white blood cells. J. Cell Sci. 73:1985;187-206.
98. Tarantino M.D., Kunicki T.J., Nugent D.J. The estrogen receptor is present in human megakaryocytes. Ann. NY Acad. Sci. 714:1994;293-296.
99. 2+ responses in untreated depressed patients and imipramine responders in remission. Biol. Psychiatry. 45:1999;1042-1048.
100. Turecki G., Briere R., Dewar K., Antonetti T., Lesage A.L., Seguin M., Chawky N., Vanier C., Alda M., Joober R., Benkelfat C., Rouleau G.A. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am. J. Psychiatry. 156:1999;1456-1458.
101. Wood K., Swade C., Abou-Saleh M., Coppen A. Peripheral serotonergic receptor sensitivity in depressive illness. J. Affect. Disord. 7:1984;59-65.
102. Wood K., Swade C., Coppen A. Platelet α-adrenergic receptors in depression: Ligand binding and aggregation studies. Acta Pharmacol. Toxicol. 56:1985;203-211.
103. Yamawaki S., Kagaya A., Okamoto Y., Shimizu M., Nishida A., Uchitomi Y. Enhanced calcium response to serotonin in platelets from patients with affective disorders. J. Psychol .Neurosci. 21:(5):1996;321-324.
104. 2 receptor changes in major depression. Biol. Psychiatry. 27:1990;489-496.
105. Zhang H.Y., Ishigaki T., Chen K., Shih J.C., Miyasato K., Ohara K., Ohara K. Serotonin2A receptor gene polymorphism in mood disorders. Biol. Psychiatry. 41:1997;768-773.